Monitoring Agency Report

Sec/Coat/66/FY2026-27 Date:28.10.2026 TheSecretary TheManager BSELimited NationalStockExchangeofIndiaLimited NewTradingWing, ExchangePlaza,C-1,Block“G” RotundaBuilding, 5 floor,BandraKurlaComplex, PScJrTiopwCeor,dDea:l5a3lS9t0r4ee6t, BSaynmdbraolE:aMstA,NAKCOAT Mumbai-400001 Mumbai-400051 DearMadam/Sir, Sub:MonitoringAgencyReportforthequarterendedSeptember30,2026 Ref: Regulation 32(6) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Regulation 41(4) of the Securities and ExchangeBoardofIndia(InitialCapitalandDisclosureRequirements)Regulations,2018 DearSir/Ma’am, Pursuant to Regulation 32(6) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015readwith Regulation41(4)oftheSEBI(IssueofCapitalandDisclosureRequirements)Regulations, 2018, we are enclosing herewith Monitoring Agency Report issued by CARE Ratings Limited, Monitoring Agency, for the quarter ended September30, 2026 in respect of utilization of proceeds of the Preferential Allotment of the Company. Theaboveisforyourinformationandrecord. TFohranMkainngakyosuia, CoatedMetals&IndustriesLimited Yoursfaithfully, ShrutiAgarwal CompanySecretary&ComplianceOfficer MembershipNo.:F12124 No. CARE/KRO/GEN/2026-27/1078 The Board of Directors Manaksia Coated Metals and Industries Limited 3rd Floor 8/1 Bikaner Building Lalbazar Street Dalahouse, Kolkata 700001 October 28, 2026 Dear Sir/Ma’am, Monitoring Agency Report for the quarter ended September 30, 2026 - in relation to the Preferential Issue of Manaksia Coated Metals and Industries Limited (“the Company”) We write in our capacity of Monitoring Agency for the Rights Issue for the amount aggregating to Rs. 134.55 crore of the Company and refer to our duties cast under 162A of the Securities & Exchange Board of India (Issue of Capital & Disclosure Requirements) Regulations. In this connection, we are enclosing the Monitoring Agency Report for the quarter ended September 30, 2026, as per aforesaid SEBI Regulations and Monitoring Agency Agreement dated December 16, 2024. Request you to kindly take the same on records. Thanking you, Yours faithfully, Kamal Mahipal Associate Director Kamal.Mahipal@careedge.in CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Report of the Monitoring Agency Name of the issuer: Manaksia Coated Metals and Industries Limited For quarter ended: September 30, 2026 Name of the Monitoring Agency: CARE Ratings Limited (a) Deviation from the objects: Nil (b) Range of Deviation: Not Applicable Declaration: We declare that this report provides an objective view of the utilization of the issue proceeds in relation to the objects of the issue based on the information provided by the Issuer and information obtained from sources believed by it to be accurate and reliable. The MA does not perform an audit and undertakes no independent verification of any information/ certifications/ statements it receives. This Report is not intended to create any legally binding obligations on the MA which accepts no responsibility, whatsoever, for loss or damage from the use of the said information. The views and opinions expressed herein do not constitute the opinion of MA to deal in any security of the Issuer in any manner whatsoever. Nothing mentioned in this report is intended to or should be construed as creating a fiduciary relationship between the MA and any issuer or between the agency and any user of this report. The MA and its affiliates also do not act as an expert as defined under Section 2(38) of the Companies Act, 2013. The MA or its affiliates may have credit rating or other commercial transactions with the entity to which the report pertains and may receive separate compensation for its ratings and certain credit related analyses. We confirm that there is no conflict of interest in such relationship/interest while monitoring and reporting the utilization of the issue proceeds by the issuer, or while undertaking credit rating or other commercial transactions with the entity. We have submitted the report herewith in line with the format prescribed by SEBI, capturing our comments, where applicable. There are certain sections of the report under the title “Comments of the Board of Directors”, that shall be captured by the Issuer’s Management / Audit Committee of the Board of Directors subsequent to the MA submitting their report to the issuer and before dissemination of the report through stock exchanges. These sections have not been reviewed by the MA, and the MA takes no responsibility for such comments of the issuer’s Management/Board. Signature: Name and designation of the Authorized Signatory: Kamal Mahipal Designation of Authorized person/Signing Authority: Associate Director CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital 15 Park Street, Kolkata – 700016 Road, Off Eastern Express Highway, Sion (East), Phone: +91-33-4018 1600/2283 1803 Mumbai - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 1) Issuer Details: Name of the issuer : Manaksia Coated Metals and Industries Limited Name of the promoter : Sushil Kumar Agrawal, Devansh Agrawal and others Industry/sector to which it belongs : Manufacturing 2) Issue Details Issue Period : January 30, 2025 Type of issue (public/rights) : Preferential Issue Type of specified securities : Convertible warrants IPO Grading, if any : Not Applicable Issue size (in crore) : Rs. 134.55 crore 3) Details of the arrangement made to ensure the monitoring of issue proceeds: Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors The company had utilized the funds No comments as per the offer document. Further, 2,000,000 convertible warrants were forfeited in accordance with the Board Board Resolution dated August 04, 2026, Resolution dated August 4, 2026, Whether all utilization is as per the disclosures in the Offer Yes Statutory Auditor’s certificate*, Bank consequent to the non-payment of Document? statements, Management certificate the remaining 75% of the warrant subscription consideration by the due date of July 31, 2026. As per CA certificate, it provides limited assurance to the details in the certificate and states "The CARE Ratings Limited Unit No. A/7/4, 7th Floor Block A, Apeejay House, 4th Floor, Godrej Coliseum, Somaiya Hospital Road, 15 Park Street, Kolkata – 700016 Off Eastern Express Highway, Sion (East), Mumbai Phone: +91-33-4018 1600/2283 1803 - 400 022 Phone: +91-22-6754 3456 • www.careedge.in CIN-L67190MH1993PLC071691 Source of information / certifications Comments of the Comments of the Particulars Reply considered by Monitoring Agency for Board of Monitoring Agency preparation of report Directors procedures performed vary in nature and timing from, and are in extent than, for a reasonable assurance. Consequently, the level of assurance obtained is substantially lower than the assurance that would have been obtained had a reasonable assurance engagement been performed." Whether shareholder approval has been obtained in case of material deviations# from expenditures disclosed in the Offer Not Applicable Management certificate Nil Nil Document? Whether the means of finance for the disclosed objects of the No Management certificate Nil Nil issue have changed? The Board forfeited 20,00,000 convertible As stated above, the total issue size warrants (Rs. 9.75 has been reduced by Rs.9.75 crore crore) on August Previous MA report for the quarter ended against which the company has not 4, 2026, due to Is there any major devi [Showing first 8,000 characters — download PDF for full document]